Skip to main content

Table 1 Participant baseline characteristics in the NHS development and validation cohorts and in BWHS

From: A model for predicting both breast cancer risk and non-breast cancer death among women > 55 years old

 

NHS development cohort

NHS validation cohorta

BWHS (Crude)

BWHS (Age-standardized)a

N

55,553

27,777

17,380

17,380

Factors in our final model

Age, mean (SD)

70.1 (7.0)

70.2 (7.0)

63.7 (6.7)

–

 55–59 years, %

7.1

6.7

36.5

–

 60–64 years, %

21.4

21.5

28.3

–

 65–69 years, %

22.4

22.3

17.1

–

 70–74 years, %

20.9

20.8

9.9

–

 75–79 years, %

18.1

18.8

5.8

–

 80+ years, %

10.1

10.0

2.4

–

Highest self-reported Body Mass Index (BMI) in past 10 years kg/m2, mean (SD)

28.1 (5.7)

28.1 (5.8)

32.1 (7.0)

31.6 (6.5)

Highest self-reported BMI in past 10 years

 < 20 kg/m2, %

2.7

2.7

0.5

0.5

 20–22.4 kg/m2, %

10.9

11.2

3.0

3.0

 22.5–24.9 kg/m2, %

19.1

19.4

8.5

9.2

 25–29.9 kg/m2, %

36.5

36.3

31.6

33.7

 30–34.9 kg/m2, %

19.5

18.9

28.3

28.0

 35–39.9 kg/m2, %

7.1

7.3

14.5

13.5

 40+ kg/m2, %

4.1

4.1

12.6

10.7

 Unknown, %

0.1

0.2

1.0

1.3

Average alcohol use per day (highest average use in past 10 years)b

 None, %

37.0

37.0

50.4

54.1

 1–4.9 g/day, %

22.5

22.7

26.0

23.9

 5–14.9 g/day, %

17.5

17.1

13.7

12.6

 15+ g/day, %

13.1

13.4

9.9

9.3

 Unknown, %

10.0

9.8

–

–

Cigarette use

 Never

44.7

44.8

53.4

50.5

 Current

7.7

7.9

10.1

8.0

 Past

47.4

47.1

36.4

41.5

 Unknown

0.2

0.2

–

–

Limited from walking several blocksc

 Not at all

61.8

61.5

–

–

 A little or a lot

32.8

33.1

–

–

 Unknown, %

5.4

5.4

–

–

Limited in bathing or dressing oneselfc

 Not at all

88.2

87.9

–

–

 A little or a lot

6.5

6.8

–

–

 Unknown, %

5.3

5.3

–

–

Usual walking pace outdoors

 Unable to walkc

2.6

2.8

–

–

 Slow or average (less than 3 mph)

73.1

72.6

62.0

65.1

 Brisk/very brisk (≥ 3 mph)

19.7

20.0

27.5

23.3

 Unknown, %

4.6

4.6

10.6

11.6

High Blood pressured

60.3

60.3

68.7

75.4

Depression

20.4

20.5

22.2

19.4

Hip fracture

2.1

2.2

0.8

1.1

Parkinson’s disease

0.7

0.6

0.2

0.3

Myocardial infarction

5.5

5.7

4.3

6.5

Congestive heart failure

3.3

3.4

3.2

4.6

Stroke/transient ischemic attack

7.5

7.5

4.2

5.7

Emphysema/Asthma

18.6

18.5

18.3

18.0

Diabetes

12.2

11.7

24.2

28.5

Dementia

1.2

1.2

0.2

0.5

Kidney disease

0.5

0.6

1.9

2.3

Cancer (excluding non-melanomatous skin cancers)

12.3

12.2

5.7

7.4

Age at menopause (years)

 < 45, %

10.8

10.4

19.3

21.2

 45–49, %

23.4

23.9

20.1

19.2

 50–54, %

56.1

56.2

27.4

25.9

 55+, %

8.8

8.5

8.3

10.6

 Hysterectomy, age unknown, %e

–

–

22.2

21.9

 Unknown, %

1.0

1.0

2.7

1.2

Mammogram in past 2 yearsf

 No

12.1

12.2

14.0

15.2

 Yes

79.4

79.5

86.0

84.8

 Unknown

8.5

8.3

–

–

Number of breast biopsies

 0, %

73.2

73.2

67.0

65.7

 1, %

23.5

23.6

21.3

21.3

 2+, %

3.3

3.2

11.7

13.1

Postmenopausal hormone use

 Never, %

22.5

22.9

40.7

37.5

 Current estrogen plus progestin user < 5 years, %

0.4

0.5

0.7

0.2

 Current estrogen plus progestin user 5 + years, %

2.7

2.7

1.1

0.8

 Current estrogen-alone user < 5 years, %

0.9

0.8

1.6

0.7

 Current estrogen-alone user 5 + years, %

9.4

9.1

6.3

5.6

 Past estrogen plus progestin user < 5 years, %

14.9

14.9

12.8

12.5

 Past estrogen plus progestin user 5 + years, %

15.8

16.1

5.6

7.4

 Past estrogen-alone user < 5 years, %

7.1

7.2

12.2

12.2

 Past estrogen-alone user 5 + years, %

13.8

13.8

13.8

18.1

 Unknown, %

12.6

12.2

5.3

4.8

Age at first birth (years) and parityg

 Nulliparous

5.3

5.4

16.0

12.7

 < 25, 1–2 children

14.2

13.9

32.2

35.4

 < 25, 3+ children

35.2

34.9

27.8

28.3

 25–29, 1–2 children

14.8

15.3

11.9

10.8

 25–29, 3+ children

20.1

20.3

2.9

4.0

 30+, 1–2 children

5.8

5.8

7.1

6.3

 30+, 3+ children

2.8

2.8

0.5

0.6

 Unknown

1.8

1.7

1.6

1.9

Number of first-degree relatives with history of breast cancer and age at diagnosish

 None, %

82.1

81.9

80.1

79.8

 1 and age < 50, %

4.3

4.1

3.8

4.2

 1 and age 50+, %

11.6

11.8

14.2

14.0

 2+ and at least one age < 50, %

1.0

1.1

0.6

0.7

 2+ and age 50+, %

1.1

1.1

1.3

1.3

Outcomes

Breast cancer in 5-year follow-up, %

1.7

1.7

1.7

1.8

Breast cancer in 10-year follow-up, %

3.1

3.2

3.1

3.2

Breast cancer death in 5-year follow-up, %

0.1

0.1

0.2

0.2

Breast cancer death in 10-year follow-up, %

0.3

0.2

0.4

0.6

Non-breast cancer death 5-year follow-up, %

7.7

8.0

4.5

8.1

Non-breast cancer death 10-year follow-up, %

20.1

20.6

11.1

19.7

Not included in model

Race/ethnicity

Non-Hispanic White, %

96.2

96.3

0.0

0.0

Non-Hispanic Black, %

1.8

1.6

99.1

99.9

Hispanic,%

0.9

0.9

0.9

0.1

Asian, Pacific Islander %

0.8

0.9

0.0

0.0

Native American, %

0.2

0.2

0.0

0.0

Education (years)i

 < 12

–

–

2.7

4.0

 12

–

–

16.4

19.1

 13–15

–

–

27.8

26.2

 16

91.7

91.7

19.5

17.1

 17+

8.4

8.4

33.6

33.5

Unknown

0.0

0.0

0.1

0.1

Predicted mammographic densityj

n = 35,073

n = 17,482

  

Higher than median (≥ 24.7% dense)

50.0

50.1

–

–

Lower than median (< 24.7% dense)

50.0

49.9

–

–

  1. NHS (Nurses’ Health Study) included participants that completed the 2004 questionnaire. BWHS (Black Women’s Health Study) included participants that completed the 2009 questionnaire
  2. aThere were no significant differences between the NHS development and validation cohorts, except for limited bathing/dressing (p = 0.04) and diabetes (p = 0.04). All comparisons between NHS development cohort and the BWHS age-standardized cohort were statistically significant except for emphysema/asthma, 5- and 10-year breast cancer incidence, and 5- and 10-year non-breast cancer death incidence. To calculate the age-standardized values for BWHS, we weighted each of six 5-year age groups, where the weight corresponded to the proportion of that age group in the whole NHS sample, and then summed the weighted age-specific values to get the overall adjusted prevalence
  3. bA standard drink is any drink that contains about 14 g of pure alcohol (12 oz. of beer, 5 oz. of wine or 1.5 oz. of liquor)
  4. cBWHS does not ask about participants’ about walking several blocks, limitations in bathing or dressing oneself, or inability to walk
  5. dHealth conditions were self-reported
  6. eParticipants with hysterectomy and age at menopause unknown in BWHS were placed in the 45–49 years category for all analyses; sensitivity analyses were performed showing no significant difference when placed in any other age category
  7. fParticipants missing data on mammography use in NHS had completed a short version of the 2004 questionnaire
  8. gParticipants who were parous with an unknown number of children were categorized as having 1–2 children
  9. hRelatives with an unknown age at diagnosis were categorized as having been diagnosed at 50 + years of age
  10. iParticipants in NHS who had a master’s or doctorate degree were placed in the 17 + years category. All others were placed in the 16 years category, as registered nurses, (22.8% of these specifically reported a Bachelor’s degree)
  11. jPredicted mammographic density was defined using a 9-item validated index. Prevalence is reported for those with complete data for the prediction model [18]
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us